2025 Global Diagnostics Review
|

OncoFirm Diagnostics: Rapid Cancer Screening for Global Health Impact


Mission: Empowering public health systems worldwide with fast, accurate, and affordable cancer diagnostics—delivered wherever they are needed most.


Why Early Detection Matters: Cancer is a leading cause of death globally, with low- and middle-income countries disproportionately affected due to limited access to diagnostic tools. Early detection dramatically improves survival rates, but traditional lab-based testing is expensive, infrastructure-heavy, and slow.


OncoFirm’s Solution: Rapid, Point-of-Care Cancer Test Kits

OncoFirm’s lateral flow-based test kits detect cancer-specific biomarkers in 10–20 minutes using a small sample of blood, saliva, or urine. These tests are designed for frontline use—no labs, electricity, or refrigeration required.

Key Benefits for Public Health Programs:

  • Accessible: Ideal for rural clinics, mobile units, and humanitarian missions
  • Cost-Effective: Lower per-test cost for large-scale screening
  • Scalable: Easy to train and deploy across broad geographies
  • Non-Invasive: Increased patient compliance with saliva/urine tests
  • Rapid Results: Real-time decision-making for clinicians

Who We Serve:

  • Ministries of Health
  • National cancer control programs
  • NGOs and nonprofit healthcare providers
  • Community-based outreach initiatives
  • International health organizations

Partnership Opportunities:

  • Bulk purchasing and national deployment plans
  • Co-branded initiatives for cancer awareness and testing
  • Joint grant applications and pilot studies
  • Integration into telemedicine and mobile screening platforms

Contact Us To explore partnership opportunities or request a demo:

Email: partnerships@oncofirmdiagnostics.com
Website: www.oncofirmdiagnostics.com
Phone: +1 (123) 456-7890


OncoFirm Diagnostics | Fast. Accessible. Life-Saving.

Similar Posts